Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy

Thumbnail
Metadata only
Author
Grzmil, Michal
Seebacher, Jan
Hess, Daniel
Behe, Martin
Schibli, Roger
Moncayo, Gerald
Frank, Stephan
Hemmings, Brian A.
Show all
Date
2016-09
Type
  • Journal Article
Publication status
published
External links
Search via SFX
Journal / series
Cellular signalling
Volume
28(9)
Pages
1412 - 1421
Publisher
Elsevier
Subject
MNK; eIF4E; eIF4G; Glioma; MTC; Temozolomide
Organisational unit
03688 - Schibli, Roger
Notes
Received 12 May 2016, Revised 7 June 2016, Accepted 7 June 2016, Published online 8 June 2016.
More
Show all metadata
Citations
Cited 9 times in Web of Science
Altmetrics